TBMED aims to support med-tech companies in the development of high-risk medical devices by reducing their time-to-market for the European sector.

TBMED will help European SMEs to maintain their competitiveness and innovation capacity in the face of global competition, e.g. from larger providers. Its aim is to minimize time-to-market and efforts for reimbursement and make medical devices accessible to patients more easily.

Upcoming events

3rd REFINE Knowledge Exchange Conference

January 26, 2022 — January 27, 2022
Hybrid event

Facts and Figures

4 years
Duration

4 years

4 Countries
13 Partners

4 Countries

8.5 M €
Funding

8.5 M €

Consortium